These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9818542)
21. The immunopathogenesis and immunotherapy of autoimmune disease. Kingsley G; Watts R J R Coll Physicians Lond; 1993 Jan; 27(1):59-64. PubMed ID: 8093906 [TBL] [Abstract][Full Text] [Related]
22. Anti-granulocyte antibodies in immune neutropenia and autoimmune disorders. Sipos A; Sonkoly I; Czirják L; Sipka S; Szabó G; Boros P; Szegedi G Acta Paediatr Hung; 1988-1989; 29(1-2):97-100. PubMed ID: 3255419 [No Abstract] [Full Text] [Related]
23. Microchimeric cells: guardians or actors of immunity in scleroderma? Lambert NC Rheumatology (Oxford); 2007 Mar; 46(3):382-3. PubMed ID: 17124252 [No Abstract] [Full Text] [Related]
24. The Autoimmune Tautology with a Focus on Systemic Sclerosis. Anaya JM Isr Med Assoc J; 2017 Mar; 19(3):186-187. PubMed ID: 28457099 [No Abstract] [Full Text] [Related]
25. [Complement and its components in selected autoimmune diseases]. Pietruska Z Pol Tyg Lek; 1980 Jan; 35(1):27-30. PubMed ID: 6154287 [No Abstract] [Full Text] [Related]
26. Pathogenesis of scleroderma. Current concepts. Lee EB; Anhalt GJ; Voorhees JJ; Diaz LA Int J Dermatol; 1984 Mar; 23(2):85-9. PubMed ID: 6698691 [No Abstract] [Full Text] [Related]
27. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma. Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085 [TBL] [Abstract][Full Text] [Related]
28. [High dose chemotherapy procedures supported by hemopoietic stem cell transplantation in treatment of autoimmune diseases]. Skotnicki AB; Wójcik MA Pol Arch Med Wewn; 2001; 105 Suppl():167-71. PubMed ID: 12412243 [No Abstract] [Full Text] [Related]
29. The presence of dominant T-cell clones in peripheral blood of patients with collagen vascular disorders: a prospective study of 97 cases. Dereure O; Gubler B; Bessis D; Guillot B; Guilhou JJ; Clot J; Eliaou JF Br J Dermatol; 2006 Mar; 154(3):445-9. PubMed ID: 16445773 [TBL] [Abstract][Full Text] [Related]
38. The endothelium: its role in scleroderma. Pearson JD Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):866-71. PubMed ID: 1750799 [No Abstract] [Full Text] [Related]
39. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma). Kondo H; Rabin BS; Rodnan GP J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970 [TBL] [Abstract][Full Text] [Related]
40. The role of semaphorins in immune responses and autoimmune rheumatic diseases. Nishide M; Kumanogoh A Nat Rev Rheumatol; 2018 Jan; 14(1):19-31. PubMed ID: 29213125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]